Laronde: Flagship's Laronde, Senda Form Company Focused on New Class of Medicines
Sail Biomedicines combines Laronde's circular eRNA platform with Senda's nanoparticle delivery technology in the pursuit of a new class of programmable medicines across therapeutic areas.
Read full article »
Laronde is a Massachusetts-based biotechnology firm that researches and develops novel eRNA therapeutics for the treatment of cancer.
Read more